S EG. Type I diabetes mellitus. A chronic autoimmune disease. N Engl J Med. 1986;314:1360–8.

Google Scholar 

DiMeglio LA, Evans-Molina C, Oram RA. Type 1 diabetes. Lancet. 2018;391:2449–62.

Article  PubMed  PubMed Central  Google Scholar 

Bluestone JA, Buckner JH, Herold KC. Immunotherapy: Building a bridge to a cure for type 1 diabetes. Science. 2021;373:510–6.

Article  CAS  PubMed  Google Scholar 

Martin-Gallausiaux C, Marinelli L, Blottière HM, Larraufie P, Lapaque N. SCFA: mechanisms and functional importance in the gut. Proc Nutr Soc. 2021;80:37–49.

Article  CAS  PubMed  Google Scholar 

Pan LL, Ren ZN, Yang J, Li BB, Huang YW, Song DX, et al. Gut microbiota controls the development of chronic pancreatitis: A critical role of short-chain fatty acids-producing Gram-positive bacteria. Acta Pharm Sin B. 2023;13:4202–16.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Vatanen T, Franzosa EA, Schwager R, Tripathi S, Arthur TD, Vehik K, et al. The human gut microbiome in early-onset type 1 diabetes from the TEDDY study. Nature. 2018;562:589–94.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huang J, Pearson JA, Peng J, Hu Y, Sha S, Xing Y, et al. Gut microbial metabolites alter IgA immunity in type 1 diabetes. JCI Insight. 2020;5:e135718.

Article  PubMed  PubMed Central  Google Scholar 

Brown AJ, Goldsworthy SM, Barnes AA, Eilert MM, Tcheang L, Daniels D, et al. The Orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. J Biol Chem. 2003;278:11312–9.

Article  CAS  PubMed  Google Scholar 

Yang W, Yu T, Huang X, Bilotta AJ, Xu L, Lu Y, et al. Intestinal microbiota-derived short-chain fatty acids regulation of immune cell IL-22 production and gut immunity. Nat Commun. 2020;11:4457.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nakajima A, Kaga N, Nakanishi Y, Ohno H, Miyamoto J, Kimura I, et al. Maternal high fiber diet during pregnancy and lactation influences regulatory T cell differentiation in offspring in mice. J Immunol. 2017;199:3516–24.

Article  CAS  PubMed  Google Scholar 

Iraporda C, Errea A, Romanin DE, Cayet D, Pereyra E, Pignataro O, et al. Lactate and short-chain fatty acids produced by microbial fermentation downregulate proinflammatory responses in intestinal epithelial cells and myeloid cells. Immunobiology. 2015;220:1161–9.

Article  CAS  PubMed  Google Scholar 

Nastasi C, Candela M, Bonefeld CM, Geisler C, Hansen M, Krejsgaard T, et al. The effect of short-chain fatty acids on human monocyte-derived dendritic cells. Sci Rep. 2015;5:16148.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liang W, Enée E, Andre-Vallee C, Falcone M, Sun J, Diana J. Intestinal cathelicidin antimicrobial peptide shapes a protective neonatal gut microbiota against pancreatic autoimmunity. Gastroenterology. 2022;162:1288–302.e16.

Article  CAS  PubMed  Google Scholar 

Turley S, Poirot L, Hattori M, Benoist C, Mathis D. Physiological beta cell death triggers priming of self-reactive T cells by dendritic cells in a type-1 diabetes model. J Exp Med. 2003;198:1527–37.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Khan FU, Khongorzul P, Raki AA, Rajasekaran A, Gris D, Amrani A. Dendritic cells and their immunotherapeutic potential for treating type 1 diabetes. Int J Mol Sci. 2022;23:4885.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Saxena V, Ondr JK, Magnusen AF, Munn DH, Katz JD. The countervailing actions of myeloid and plasmacytoid dendritic cells control autoimmune diabetes in the nonobese diabetic mouse. J Immunol. 2007;179:5041–53.

Article  CAS  PubMed  Google Scholar 

Nikolic T, Suwandi JS, Wesselius J, Laban S, Joosten AM, Sonneveld P, et al. Tolerogenic dendritic cells pulsed with islet antigen induce long-term reduction in T-cell autoreactivity in type 1 diabetes patients. Front Immunol. 2022;13:1054968.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zerif E, Maalem A, Gaudreau S, Guindi C, Ramzan M, Véroneau S, et al. Constitutively active Stat5b signaling confers tolerogenic functions to dendritic cells of NOD mice and halts diabetes progression. J Autoimmun. 2017;76:63–74.

Article  CAS  PubMed  Google Scholar 

Trompette A, Gollwitzer ES, Yadava K, Sichelstiel AK, Sprenger N, Ngom-Bru C, et al. Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis. Nat Med. 2014;20:159–66.

Article  CAS  PubMed  Google Scholar 

Bellahcene M, O’Dowd JF, Wargent ET, Zaibi MS, Hislop DC, Ngala RA, et al. Male mice that lack the G-protein-coupled receptor GPR41 have low energy expenditure and increased body fat content. Br J Nutr. 2013;109:1755–64.

Article  CAS  PubMed  Google Scholar 

Jia LL, Li JH, Zhang M, Liu H, Ren ZN, Dong XL, et al. Cathelicidin-related antimicrobial peptide protects against enteric pathogen-accelerated type 1 diabetes in mice. Theranostics. 2022;12:3438–55.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Roney K. Bone marrow-derived dendritic cells. Methods Mol Biol. 2019;1960:57–62.

Article  CAS  PubMed  Google Scholar 

Kaminitz A, Mizrahi K, Yaniv I, Stein J, Askenasy N. Immunosuppressive therapy exacerbates autoimmunity in NOD mice and diminishes the protective activity of regulatory T cells. J Autoimmun. 2010;35:145–52.

Article  CAS  PubMed  Google Scholar 

Kaminitz A, Mizrahi K, Yaniv I, Farkas DL, Stein J, Askenasy N. Low levels of allogeneic but not syngeneic hematopoietic chimerism reverse autoimmune insulitis in prediabetic NOD mice. J Autoimmun. 2009;33:83–91.

Article  CAS  PubMed  Google Scholar 

Chen K, Chen H, Faas MM, de Haan BJ, Li J, Xiao P, et al. Specific inulin-type fructan fibers protect against autoimmune diabetes by modulating gut immunity, barrier function, and microbiota homeostasis. Mol Nutr Food Res. 2017;61:1601006.

Pearson JA, Wong FS, Wen L. The importance of the Non Obese Diabetic (NOD) mouse model in autoimmune diabetes. J Autoimmun. 2016;66:76–88.

Article  CAS  PubMed  Google Scholar 

Jia LL, Zhang M, Liu H, Sun J, Pan LL. Early-life fingolimod treatment improves intestinal homeostasis and pancreatic immune tolerance in non-obese diabetic mice. Acta Pharmacol Sin. 2021;42:1620–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pan X, Fang X, Wang F, Li H, Niu W, Liang W, et al. Butyrate ameliorates caerulein-induced acute pancreatitis and associated intestinal injury by tissue-specific mechanisms. Br J Pharmacol. 2019;176:4446–61.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ang Z, Ding JL. GPR41 and GPR43 in obesity and inflammation-protective or causative? Front Immunol. 2016;7:28.

Article  PubMed  PubMed Central  Google Scholar 

Chang G, Zhang H, Wang Y, Ma N, Chandra RA, Ye G, et al. Microbial community shifts elicit inflammation in the caecal mucosa via the GPR41/43 signalling pathway during subacute ruminal acidosis. BMC Vet Res. 2019;15:298.

Article  PubMed  PubMed Central  Google Scholar 

Duca FA, Swartz TD, Sakar Y, Covasa M. Increased oral detection, but decreased intestinal signaling for fats in mice lacking gut microbiota. PLoS One. 2012;7:e39748.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sun J, Furio L, Mecheri R, van der Does AM, Lundeberg E, Saveanu L, et al. Pancreatic beta-cells limit autoimmune diabetes via an immunoregulatory antimicrobial peptide expressed under the influence of the gut microbiota. Immunity. 2015;43:304–17.

Article  CAS  PubMed  Google Scholar 

Wurster JI, Peterson RL, Brown CE, Penumutchu S, Guzior DV, Neugebauer K, et al. Streptozotocin-induced hyperglycemia alters the cecal metabolome and exacerbates antibiotic-induced dysbiosis. Cell Rep. 2021;37:110113.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Graham S, Courtois P, Malaisse WJ, Rozing J, Scott FW, Mowat AM. Enteropathy precedes type 1 diabetes in the BB rat. Gut. 2004;53:1437–44.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Patrick C, Wang GS, Lefebvre DE, Crookshank JA, Sonier B, Eberhard C, et al. Promotion of autoimmune diabetes by cereal diet in the presence or absence of microbes associated with gut immune activation, regulatory imbalance, and altered cathelicidin antimicrobial peptide. Diabetes. 2013;62:2036–47.

Article  CAS  PubMed  PubMed Central  Google Scholar